| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ARRAY BIOPHARMA INC | 1,650,000 | 14,504,000 | 0.60% | ||
| 52 | AAC HLDGS INC | 1,975,347 | 14,302,000 | 0.59% | ||
| 53 | SPARK THERAPEUTICS INCORPORATED | 283,000 | 14,122,000 | 0.58% | ||
| 54 | FOAMIX PHARMACEUTICALS LTD | 1,232,844 | 13,685,000 | 0.56% | ||
| 55 | GLAUKOS CORP | 393,228 | 13,488,000 | 0.55% | ||
| 56 | KITE PHARMA INCORPORATED | 297,902 | 13,358,000 | 0.55% | ||
| 57 | WAVE LIFE SCIENCES LTD | 472,124 | 12,346,000 | 0.51% | ||
| 58 | ADEPTUS HEALTH INC | 1,600,861 | 12,231,000 | 0.50% | ||
| 59 | CYTOMX THERAPEUTICS INC COM | 943,433 | 10,368,000 | 0.43% | ||
| 60 | IONIS PHARMACEUTICALS INC COM | 214,095 | 10,240,000 | 0.42% | ||
| 61 | ACLARIS THERAPEUTICS INC COM | 375,000 | 10,178,000 | 0.42% | ||
| 62 | INVUITY INC | 1,690,498 | 9,720,000 | 0.40% | ||
| 63 | Nivalis Therapeutics Inc | 3,732,412 | 8,361,000 | 0.34% | ||
| 64 | AKARI THERAPEUTICS PLC | 1,150,700 | 8,101,000 | 0.33% | ||
| 65 | LOXO ONCOLOGY INC COM | 251,000 | 8,061,000 | 0.33% | ||
| 66 | Oxford Immunotec Global PLC | 529,197 | 7,911,000 | 0.33% | ||
| 67 | KERYX BIOPHARMACEUTICALS INCORPORATED | 1,291,531 | 7,568,000 | 0.31% | ||
| 68 | ARALEZ PHARMACEUTICALS INC | 1,644,583 | 7,253,000 | 0.30% | ||
| 69 | Axovant Sciences LTD | 568,005 | 7,055,000 | 0.29% | ||
| 70 | FIVE PRIME THERAPEUTICS INC | 138,000 | 6,915,000 | 0.28% | ||
| 71 | EXACT SCIENCES CORP | 500,000 | 6,680,000 | 0.27% | ||
| 72 | ALIMERA SCIENCES INC | 5,878,015 | 6,348,000 | 0.26% | ||
| 73 | ADVANCED ACCELERATOR APPLIC | 210,000 | 5,620,000 | 0.23% | ||
| 74 | MYOKARDIA INC | 424,800 | 5,501,000 | 0.23% | ||
| 75 | ARDELYX INC COM | 373,643 | 5,306,000 | 0.22% | ||
| 76 | CAS MED SYS INC | 3,200,000 | 5,152,000 | 0.21% | ||
| 77 | RA PHARMACEUTICALS INC COM | 323,630 | 4,916,000 | 0.20% | ||
| 78 | ESSA Pharma | 2,121,601 | 4,646,000 | 0.19% | ||
| 79 | STEADYMED LTD | 1,756,370 | 4,567,000 | 0.19% | ||
| 80 | SCYNEXIS INC | 1,048,000 | 3,343,000 | 0.14% | ||
| 81 | KEMPHARM INC | 1,084,443 | 3,199,000 | 0.13% | ||
| 82 | NANOSTRING TECHNOLOGIES INC | 139,000 | 3,100,000 | 0.13% | ||
| 83 | VOYAGER THERAPEUTICS INC | 235,294 | 2,998,000 | 0.12% | ||
| 84 | GENOCEA BIOSCIENCES INC | 687,257 | 2,831,000 | 0.12% | ||
| 85 | SANGAMO THERAPEUTICS INCORPORATED | 837,963 | 2,556,000 | 0.11% | ||
| 86 | PSIVIDA CORP | 1,492,824 | 2,553,000 | 0.11% | ||
| 87 | Proteon Therapeutics Inc | 1,332,599 | 2,532,000 | 0.10% | ||
| 88 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 171,428 | 2,477,000 | 0.10% | ||
| 89 | Catabasis Pharmaceuticals Inc | 682,940 | 2,465,000 | 0.10% | ||
| 90 | PROTEOSTASIS THERAPEUTICS IN COM | 186,000 | 2,280,000 | 0.09% | ||
| 91 | Agile Therapeutics, Inc. | 398,000 | 2,269,000 | 0.09% | ||
| 92 | CELLDEX THERAPEUTICS INC NEW | 632,944 | 2,241,000 | 0.09% | ||
| 93 | BIOSCRIP INC | 1,971,228 | 2,050,000 | 0.08% | ||
| 94 | Sierra Oncology, Inc. | 1,166,619 | 1,738,000 | 0.07% | ||
| 95 | Hercules Offshore Inc | 76,000 | 1,729,000 | 0.07% | ||
| 96 | PARATEK PHARMACEUTICALS INC | 100,000 | 1,540,000 | 0.06% | ||
| 97 | NOVELION THERAPEUTICS INC | 170,454 | 1,435,000 | 0.06% | ||
| 98 | NEOS THERAPEUTICS INC COM | 229,166 | 1,341,000 | 0.06% | ||
| 99 | OCERA THERAPEUTICS INC | 572,893 | 1,203,000 | 0.05% | ||
| 100 | THRESHOLD PHARMACEUTICAL INC | 2,202,160 | 971,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-17-007402, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
